Attached files
| file | filename |
|---|---|
| EX-32 - EXHIBIT 32.1 - PetLife Pharmaceuticals, Inc. | exhibit321.htm |
| EX-3 - EXHIBIT 3.2 - PetLife Pharmaceuticals, Inc. | exhibit32.htm |
| EX-31 - EXHIBIT 31.1 - PetLife Pharmaceuticals, Inc. | exhibit311.htm |
| EX-31 - EXHIBIT 31.2 - PetLife Pharmaceuticals, Inc. | exhibit312.htm |
| 10-K - PETLIFE PHARMACEUTICALS, INC. ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED AUGUST 31, 2014 - PetLife Pharmaceuticals, Inc. | ptlf10k2014.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. 1350)
In connection with the Annual Report of PetLife Pharmaceuticals, Inc.. (the "Company") on Form 10-K for the year ended August 31, 2014, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Sebastian Serrell-Watts, Chief Financial Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), that to my knowledge:
1.
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: December 15, 2014
\s\ Sebastian Serrell-Watts
Sebastian Serrell-Watts
Chief Financial Officer